Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Two Formulations of 0.5 mg Dutasteride Capsules in Healthy Thai Male Volunteers under Fasting Condition
TCTR20190827001Phase 1Not yet recruiting
- Sponsor
- T.O. Chemicals
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dutasteride in benign prostatic hyperplasia (BPH) (2 arms), sponsored by T.O. Chemicals. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on TCTR20190827001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190827001.